Close Menu

NEW YORK (GenomeWeb) – MDxHealth announced today that it has been awarded a US General Services Administration contract to supply its ConfirmMDx prostate cancer test to the Department of Veterans Affairs.

According to the company, the five-year contract provides coverage of ConfirmMDx testing at the Medicare rate for veterans with the VA health system beginning February 1. Additional terms were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
02
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.